Integrated Quantitative Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.71M Buy
12,011
+36
+0.3% +$5.46K 0.3% 100
2026
Q2
$1.88M Buy
+11,975
New +$1.8M 0.31% 105
2026
Q1
– Sell
-10,599
Closed -$1.46M – 510
2025
Q4
$1.46M Sell
10,599
-28
-0.3% -$3.67K 0.31% 102
2025
Q3
$1.36M Buy
10,627
+83
+0.8% +$10.1K 0.39% 59
2025
Q2
$1.28M Buy
+10,544
New +$1.19M 0.37% 66

Other funds holding NVS

Integrated Quantitative Investments's NVS Position: Q3 2026 in Review

Integrated Quantitative Investments increased its Novartis (NVS) stake by 0.3% in Q3 2026, buying an estimated $5.46K and bringing the position to 12,011 shares worth $1.71M. The position accounts for 0.3% of the portfolio, ranked #100.

Integrated Quantitative Investments first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.88M in Q2 2026. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Integrated Quantitative Investments held 12,011 shares of Novartis worth $1.71M as of Q3 2026.
  • Integrated Quantitative Investments bought 36 Novartis shares in Q3 2026, an estimated $5.46K.
  • Novartis made up 0.3% of Integrated Quantitative Investments's portfolio in Q3 2026, its #100 holding.
  • Integrated Quantitative Investments first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • Integrated Quantitative Investments's Novartis position peaked at $1.88M in Q2 2026.
  • 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.